Rhythm Pharmaceuticals has shared early results from a Phase 2 study of a drug called setmelanotide in people with Prader-Willi syndrome (PWS). This is an exciting development because it… Read More »Rhythm Pharmaceuticals announce promising early data on their trial of Setmelanotide
For families living with Prader-Willi syndrome (PWS), the relentless drive to eat is a well-known and daily struggle. A key area of PWS research is… Read More »Boosting Brain Signals to Help Regulate Appetite in PWS
A personal perspective from Professor Tony Holland We are deeply grateful to Professor Tony Holland for sharing his reflections on over 30 years of research… Read More »30+ years of research into PWS
Following our visit to the University of Cambridge last week, we have been asked to share details of an exciting new study. A research team… Read More »Mitochondria Research Opportunity
The festive season is here – a time for giving, sharing joy, and spreading hope. At FPWR UK, we’re inviting you to make this Christmas… Read More »Give The Gift of Research
A promising new development in Prader-Willi syndrome (PWS) research is underway at Bright Minds Biosciences, a biotechnology company focused on creating treatments for brain and… Read More »Bright Minds Biosciences: A New Approach to Treating PWS